Alto Neuroscience receives US patent for ALTO-207; strengthens IP portfolio for patients with treatment-resistant depression: Mountain View, California Saturday, January 17, 2026, ...

Alto Neuroscience, Inc. (NYSE: ANRO) shares began Wednesday’s session. The company, a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...

Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...

Purpose: Six non-ergot dopamine -receptor agonists (NEDAs), including pramipexole extended-release (ER), pramipexole immediate-release (IR), rotigotine patch, piribedil, ropinirole prolonged-release ...

Q. I was on a 14-day course of prednisone for vertigo. Once I stopped, I had terrible withdrawal symptoms that have persisted for more than 10 days. Luckily, they are getting better, but I’m still ...

The Federal Drug Administration said drugmakers have recalled more than 580,000 bottles of a blood pressure medication over concerns that it may include a cancer-causing chemical. New Jersey-based ...

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a ...

The dosage of celecoxib varies based on your condition and medical history, ranging from 100 to 400 milligrams (mg) per day for adults. Celecoxib’s dosage is weight-based for children with juvenile ...

Background: Periodic limb movement disorder (PLMD) is a sleep-related movement disorder, which may be accompanied by a complaint of excessive daytime sleepiness (EDS). With this study, we reported a ...